Cardiovascular aspects of primary hyperparathyroidism

Journal of Endocrinological Investigation

Volumn 31, Issue 10, 2008, Pages 925-931

  Walker, M D ^a   Silverberg, S J ^a,b  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b Department of Clinical Medicine ^*  (United States)

Author keywords

Cardiovascular; Mortality; Primary hyperparathyroidism

Indexed keywords

ARTERY INTIMA PROLIFERATION; BLOOD VESSEL CALCIFICATION; CALCIUM BLOOD LEVEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; HEART ARRHYTHMIA; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; HYPERCALCEMIA; HYPERTENSION; MORTALITY; PARATHYROIDECTOMY; PRIMARY HYPERPARATHYROIDISM; REVIEW;

EID: 58649089627     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03346443     Document Type: Review

References (69)

1. Albright F, Aub J, Bauer W. Hyperparathyroidism: a common and polymorphic condition as illustrated by seventeen proved cases from one clinic. JAMA 1934, 102: 1276-87.
2. Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 1999, 341: 1249-55.
3. Catellier MJ, Chua GT, Youmans G, Waller BF. Calcific deposits in the heart. Clin Cardiol 1990, 13: 287-94.
4. Roberts WC, Waller BF. Effect of chronic hypercalcemia on the heart. An analysis of 18 necropsy patients. Am J Med 1981, 71: 371-84.
5. Symons C, Fortune F, Greenbaum RA, Dandona P. Cardiac hypertrophy, hyper-trophic cardiomyopathy, and hyperparathyroidism - an association. Br Heart J 1985, 54: 539-42.
6. Stefenelli T, Wikman-Coffelt J, Wu ST, Parmley WW. Calcium-dependent fluorescence transients during ventricular fibrillation. Am Heart J 1990, 120: 590-7.
7. Campese VM. Calcium, parathyroid hormone, and blood pressure. Am J Hypertens 1989, 2 (Pt 2): 34S-44S.
8. Suzuki T, Aoki K. Hypertensive effects of calcium infusion in subjects with normotension and hypertension. J Hypertens 1988, 6: 1003-8.
9. Ogino K, Burkhoff D, Bilezikian JP. The hemodynamic basis for the cardiac effects of parathyroid hormone (PTH) and PTH-related protein. Endocrinology 1995, 136: 3024-30.
10. Schlüter KD, Piper HM. Trophic effects of catecholamines and parathyroid hormone on adult ventricular cardiomyocytes. Am J Physiol 1992, 263(6 Pt 2): H1739-46.
11. Palmér M, Adami HO, Bergström R, Akerström G, Ljunghall S. Mortality after surgery for primary hyperparathyrodism: a follow-up of 441 patients operated on from 1956 to 1979. Surgery 1987, 102: 1-7.
12. Ronni-Sivula H. Causes of death in patients previously operated on for primary hyperparathyroidism. Ann Chir Gynaecol 1985, 74: 13-8.
13. Hedbäck G, Tisell LE, Bengtsson BA, Hedman I, Oden A. Premature death in patients operated on for primary hyperparathyroidism. World J Sung 1990, 14: 829-35; discussion 836.
14. Ljunghall S, Jakobsson S, Joborn C, Palmér M, Rastad J, Akerström G. Longitudinal studies of mild primary hyperparathyroidism. J Bone Miner Res 1991, 6 (Suppl 2): S111-6; discussion S121-4.
15. Hedbäck G, Odén A, Tisell LE. The influence of surgery on the risk of death in patients with primary hyperparathyroidism. World J Surg 1991, 15: 399-405, discussion 406-7.
16. Söreide JA, van Heerden JA, Grant CS, Yau Lo C, Schleck C, Ilstrup DM. Survival after surgical treatment for primary hyperparathyroidism. Surgery 1997, 122: 1117-23.
17. Wermers RA, Khosla S, Atkinson EJ, et al. Survival after the diagnosis of hyperparathyroidism: a population-based study. Am J Med 1998, 104: 115-22.
18. Leifsson BG, Ahrén B. Serum calcium and survival in a large health screening program. J Clin Endocrinol Metab 1996, 81: 2149-53.
19. Nilsson IL, Yin L, Lundgren E, Rastad J, Ekbom A. Clinical presentation of primary hyperparathyroidism in Europe--nationwide cohort analysis on mortality from nonmalignant causes. J Bone Miner Res 2002, 17 (Suppl 2): N68-74.
20. Hedbäck G, Odén A. Increased risk of death from primary hyperparathyroidism -an update. Eur J Clin Invest 1998, 28: 271-6.
21. Lafferty FW. Primary hyperparathyroidism. Changing clinical spectrum, prevalence of hypertension, and discriminant analysis of laboratory tests. Arch Intern Med 1981, 141: 1761-6.
22. Nainby-Luxmoore JC, Langford HG, Nelson NC, Watson RL, Barnes TY. A case-comparison study of hypertension and hyperparathyroidism. J Clin Endocrinol Metab 1982, 55: 303-6.
23. Christensson T, Hellström K, Wengle B. Blood pressure in subjects with hypercalcaemia and primary hyperparathyroidism detected in a health screening programme. Eur J Clin Invest 1977, 7: 109-13.
24. Ringe JD. Reversible hypertension in primary hyperparathyroidism- pre- and posteroperative blood pressure in 75 cases. Klin Wochenschr 1984, 62: 465-9.
25. Rapado A. Arterial hypertension and primary hyperparathyroidism. Incidence and follow-up after parathyroidectomy. Am J Nephrol 1986, 6 (Suppl 1): 49-50.
26. Sancho JJ, Rouco J, Riera-Vidal R, Sitges-Serra A. Long-term effects of parathyroidectomy for primary hyperparathyroidism on arterial hypertension. World J Surg 1992, 16: 732-5; discussion 736.
27. Jones DB, Jones JH, Lloyd HJ, Lucas PA, Wilkins WE, Walker DA. Changes in blood pressure and renal function after parathyroidectomy in primary hyperparathyroidism. Postgrad Med J 1983, 59: 350-3.
28. Lind L, Jacobsson S, Palmér M, Lithell H, Wengle B, Ljunghall S. Cardiovascular risk factors in primary hyperparathyroidism: a 15-year follow-up of operated and unoperated cases. J Intern Med 1991, 230: 29-35.
29. Sangal AK, Kevwitch M, Rao DS, Rival J. Hypomagnesemia and hypertension in primary hyperparathyroidism. South Med J 1989, 82: 1116-8.
30. Marone C, Beretta-Piccoli C, Weidmann P. Role of haemodynamics, catecholamines and renin in acute hypercalcaemic hypertension in man. Clin Sci (Lond) 1980, 59 (Suppl 6): 369s-71s.
31. Gennari C, Nami R, Gonnelli S. Hypertension and primary hyperparathyroidism: the role of adrenergic and renin-angiotensin-aldosterone systems. Miner Electrolyte Metab 1995, 21: 77-81.
32. Nilsson IL, Rastad J, Johansson K, Lind L. Endothelial vasodilatory function and blood pressure response to local and systemic hypercalcemia. Surgery 2001, 130: 986-90.
33. Surawicz B. Role of electrolytes in etiology and management of cardiac arrhythmias. Prog Cardiovasc Dis 1966, 8: 364-86.
34. Lind L, Ljunghall S. Serum calcium and the ECG in patients with primary hyperparathyroidism. J Electrocardiol 1994, 27: 99-103.
35. Lind L, Ridefelt P, Rastad J, Akerström G, Ljunghall S. Cytoplasmic calcium regulation and the electrocardiogram in patients with primary hyperparathyroidism. Clin Physiol 1994, 14: 103-10.
36. Nilsson IL, Aberg J, Rastad J, Lind L. Maintained normalization of cardiovascular dysfunction 5 years after parathyroidectomy in primary hyperparathyroidism. Surgery 2005, 137: 632-8.
37. Rosenqvist M, Nordenström J, Andersson M, Edhag OK. Cardiac conduction in patients with hypercalcaemia due to primary hyperparathyroidism. Clin Endocrinol (Oxf) 1992, 37: 29-33.
38. Barletta G, De Feo ML, Del Bene R, et al. Cardiovascular effects of parathyroid hormone: a study in healthy subjects and normotensive patients with mild primary hyperparathyroidism. J Clin Endocrinol Metab 2000, 85: 1815-21.
39. Curione M, Letizia C, Amato S, et al. Increased risk of cardiac death in primary hyperparathyroidism: what is a role of electrical instability? Int J Cardiol 2007, 121: 200-2.
40. Almqvist EG, Bondeson AG, Bondeson L, Nissborg A, Smedgård P, Svensson SE. Cardiac dysfunction in mild primary hyperparathyroidism assessed by radionuclide angiography and echocardiography before and after parathyroidectomy. Surgery 2002, 132: 1126-32; discussion 1132.
41. Dalberg K, Brodin LA, Juhlin-Dannfelt A, Famebo LO. Cardiac function in primary hyperparathyroidism before and after operation. An echocardiographic study. Eur J Surg 1996, 162: 171-6.
42. Näppi S, Saha H, Virtanen V, et al. Left ventricular structure and function in primary hyperparathyroidism before and after parathyroidectomy. Cardiology 2000, 93: 229-33.
43. Piovesan A, Molineri N, Casasso F, et al. Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy. Clin Endocrinol (Oxf) 1999, 50: 321-8.
44. Stefenelli T, Abela C, Frank H, et al. Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up. J Clin Endocrinol Metab 1997, 82: 106-12.
45. Stefenelli T, Globits S, Bergler-Klein J, Woloszczuk W, Längle F, Niederle B. Cardiac changes in patients with hypercalcemia. Wien Klin Wochenschr 1993, 105: 339-41.
46. Nuzzo V, Tauchmanovà L, Fonderico F, et al. Increased intima-media thickness of the carotid artery wall, normal blood pressure profile and normal left ventricular mass in subjects with primary hyperparathyroidism. Eur J Endocrinol 2002, 147: 453-9.
47. Nilsson IL, Aberg J, Rastad J, Lind L. Left ventricular systolic and diastolic function and exercise testing in primary hyperparathyroidism-effects of parathyroidectomy. Surgery 2000, 128: 895-902.
48. Smith JC, Page MD, John R, et al. Augmentation of central arterial pressure in mild primary hyperparathyroidism. J Clin Endocrinol Metab 2000, 85: 3515-9.
49. Längle F, Abela C, Koller-Strametz J, et al. Primary hyperparathyroidism and the heart: cardiac abnormalities correlated to clinical and biochemical data. World J Surg 1994, 18: 619-24.
50. Stefenelli T, Mayr H, Bergler-Klein J, Globits S, Woloszczuk W, Niederle B. Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. Am J Med 1993, 95: 197-202.
51. Lind L, Skarfors E, Berglund L, Lithell H, Ljunghall S. Serum calcium: a new, independent, prospective risk factor for myocardial infarction in middle-aged men followed for 18 years. J Clin Epidemiol 1997, 50: 967-73.
52. Vestergaard P, Mollerup CL, Frøkjaer VG, Christiansen P, Blichert-Toft M, Mosekilde L. Cardiovascular events before and after surgery for primary hyperparathyroidism. World J Surg 2003, 27: 216-22.
53. Kamycheva E, Sundsfjord J, Jorde R. Serum parathyroid hormone levels predict coronary heart disease: the Tromsø study. Eur J Cardiovasc Prev Rehabil 2004, 11: 69-74.
54. Rubin MR, Rundek T, McMahon DJ, Lee HS, Sacco RL, Silverberg SJ. Carotid artery plaque thickness is associated with increased serum calcium levels: The Northern Manhattan study. Atherosclerosis 2007, 194: 426-32.
55. Nilsson IL, Aberg J, Rastad J, Lind L. Endothelial vasocilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy. Surgery 1999, 126: 1049-55.
56. Kosch M, Hausberg M, Vormbrock K, Kisters K, Rahn KH, Barenbrock M. Studies on flow-mediated vasocilation and intima-media thickness of the brachial artery in patients with primary hyperparathyroidism. Am J Hypertens 2000, 13: 759-64.
57. Kosch M, Hausberg M, Barenbrock M, Posadzy-Malaczynska A, Kisters K, Rahn KH. Arterial distensibility and pulse wave velocity in patients with primary hyperparathyroidism before and after parathyroidectomy. Clin Nephrol 2001, 55: 303-8.
58. Lumachi F, Ermani M, Frego M, et al. Intima-media thickness measurement of the carotid artery in patients with primary hyperparathyroidism. A prospective case-control study and long-term follow-up. In Vivo 2006, 20: 887-90.
59. Fallo F, Camporese G, Capitelli E, Andreozzi GM, Mantero F, Lumachi F. Ultrasound evaluation of carotid artery in primary hyperparathyroidism. J Clin Endocrinol Metab 2003, 88: 2096-9.
60. Brutsaert DL, Sys SU, Gillebert TC. Diastolic dysfunction in post-cardiac surgical management. J Cardiothorac Vasc Anesth 1993, 7 (Suppl 1): 18-20.
61. Baykan M, Erem C, Erdogan T, et al. Assessment of left ventricular diastolic function and the Tei index by tissue Doppler imaging in patients with primary hyperparathyroidism. Clin Endocrinol (Oxf) 2007, 66: 483-8.
62. Georgiannos SN, Jenkins BJ, Goode AW. Cardiac output in asymptomatic primary hyperparathyroidism: a stigma of early cardiovascular dysfunction? Int Surg 1996, 81: 171-3.
63. Neunteufl T, Katzenschlager R, Abela C, et al. Impairment of endothelium-independent vasodilation in patients with hypercalcemia. Cardiovasc Res 1998, 40: 396-401.
64. Kosch M, Hausberg M, Vormbrock K, et al. Impaired flow-mediated vasodilation of the brachial artery in patients with primary hyperparathyroidism improves after parathyroidectomy. Cardiovasc Res 2000, 47: 813-8.
65. Baykan M, Erem C, Erdogan T, et al. Impairment of flow mediated vasodilatation of brachial artery in patients with primary hyperparathyroidism. Int J Cardiovasc Imaging 2007, 23: 323-8.
66. Fardella C, Rodriguez-Portales JA. Intracellular calcium and blood pressure: comparison between primary hyperparathyroidism and essential hypertension. J Endocrinol Invest 1995, 18: 827-32.
67. Arnett DK, Evans GW, Riley WA. Arterial stiffness: a new cardiovascular risk factor? Am J Epidemiol 1994, 140: 669-82.
68. Rubin MR, Maurer MS, McMahon DJ, Bilezikian JP, Silverberg SJ. Arterial stiffness in mild primary hyperparathyroidism. J Clin Endocrinol Metab 2005, 90: 3326-30.
69. Niederle B, Stefenelli T, Glogar D, Woloszczuk W, Roka R, Mayr H. Cardiac calcific deposits in patients with primary hyperparathyroidism: preliminary results of a prospective echocardiographic study. Surgery 1990, 108: 1052-6; discussion 1056-7.